Research progress in the effect of SARS-CoV-2 infection on Alzheimer’s disease
Author:
Affiliation:

Clc Number:

R181.3+2

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    The global morbidity and mortality of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are gradually decreasing, but the elderly people are still at higher risk of death than the general population, especially for those with Alzheimer’s disease (AD) . AD is a slowly progressing degenerative disease of the nervous system, and is the most common type of dementia. Its neuropathological features include overproduction and clea-rance imbalance of amyloid β-protein and overphosphorylated tau protein leading to neurofibrillary tangle. People with AD are more susceptible to be infected with SARS-CoV-2, likewise, the virus can also cause AD in those who are infected. After SARS-CoV-2 infection, it affects AD through immune response, inflammatory response, cell aging, DNA damage reaction, autophagy disorder, choroidal homeostasis disorder, over-activation of renin-angiotensin system, and oxidative stress. This article mainly reviews the research progress in the effect of SARS-CoV-2 infection on AD.

    Reference
    Related
Get Citation

王康,张琰,赵慧,等.新型冠状病毒感染对阿尔茨海默病影响的研究进展[J].中国感染控制杂志英文版,2024,23(11):1450-1455. DOI:10.12138/j. issn.1671-9638.20246083.
WANG Kang, ZHANG Yan, ZHAO Hui, et al. Research progress in the effect of SARS-CoV-2 infection on Alzheimer’s disease[J]. Chin J Infect Control, 2024,23(11):1450-1455. DOI:10.12138/j. issn.1671-9638.20246083.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:January 25,2024
  • Revised:
  • Adopted:
  • Online: November 27,2024
  • Published: November 28,2024